Cancer Center Discoveries Bring Hope for a CureDecember 16, 2012
Another year of trailblazing research and outstanding patient care is coming to a close at the Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center. The Center’s achievements in 2012 include a significant discovery regarding glioblastoma, the most common and aggressive form of primary brain cancer. Research led by Antonio Iavarone, M.D., professor of pathology and neurology, shows that some cases of this cancer are caused by the fusion of two adjacent genes. Dr. Iavarone’s study also shows that drugs targeting the protein produced by this genetic aberration can dramatically slow the growth of glioblastomas in mice.
Stephen G. Emerson, M.D., Ph.D., director of the HICCC, called the discovery, “a very exciting advance in our understanding of cancer, and perhaps a first step toward a personalized, precision approach to the treatment of glioblastoma.”
For millions of patients and their families, cutting edge research means hope. Across the HICCC, physicians and scientists like Dr. Iavarone are striving to learn more about cancer and to turn their discoveries into therapies and cures. This important work cannot take place without the support of generous donors.
Since the 1990s, research-driven advances in care have steadily decreased the number of people who die from cancer. But much still remains to be done. The scientists and physicians at the HICCC are working hard every day to increase our understanding of cancer with the goal of saving more lives. Your support is vital to continuing their work.
With your gift, we will discover how cancer develops, how we can cure more adults and children, and why some people are more likely to develop the disease than others. Please join us in these efforts!